This scholarship page was last updated on 04 October 2022. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health

Type

Research/project funding

Posted on:

04 October 2022

Application Deadline:

Expired

Reference Number

RFA-AI-22-068

The purpose of this Funding Opportunity Announcement is to invite applications aimed at discovery of new antivirals that result in the elimination or suppression of HBV ccc DNA from infected cells.
Categories: Health.

More Information

Visit Website